Clinical trials Adding elotuzumab to lenalidomide and dexamethasone does not improve PFS in patients with newl... Read more
Clinical trials LISO-CEL SHOWS SUPERIOR EFFICACY VS. STANDARD OF CARE AS SECOND-LINE TREATMENT FOR PRIMARY REF... Read more
Clinical trials Adding ibrutinib to bendamustine and rituximab prolongs progression-free survival in older pat... Read more
Clinical trials Three-agent regimen provides ‘unprecedented’ PFS benefit in patients with relapsed multipl... Read more
Clinical trials Circulating tumour cells and disease staging in newly diagnosed multiple myeloma patients Read more
Clinical trials PTCy plus TK is safe and effective in reducing GVHD in older patients with blood cancers Read more
Clinical trials Chemoradiation limits but does not eliminate excess long-term morbidity in cHL patients Read more
Clinical trials Gilteritinib maintenance improves overall survival in relapsed /refractory FLT3+ AML Read more
Clinical trials Outcomes in adolescent and young adult patients compared to younger patients treated for high-... Read more
Top
